Clinical trials
Phase 2/3 Ischemic Stroke trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
64 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 4 |
| 2015 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2020 | 3 |
| 2021 | 6 |
| 2022 | 2 |
| 2023 | 9 |
| 2024 | 8 |
| 2025 | 8 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Unknown status | 16 |
| Recruiting | 12 |
| Not yet recruiting | 11 |
| Terminated | 6 |
| Withdrawn | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Xiang Luo | 6 |
| Capital Medical University | 3 |
| Xinqiao Hospital of Chongqing | 3 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Fudan University | 2 |
| Nanfang Hospital, Southern Medical University | 2 |
| Shanghai Yueyang Integrated Medicine Hospital | 2 |
| University of Melbourne | 2 |
| Xijing Hospital | 2 |
| Acticor Biotech | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ischemic Stroke | 64 |
| Stroke | 23 |
| Brain Diseases | 2 |
| Central Nervous System Diseases | 2 |
| Cerebral Infarction | 2 |
| Cerebrovascular Disorders | 2 |
| Hemorrhagic Stroke | 2 |
| Intracranial Arteriosclerosis | 2 |
| Ischemic Attack, Transient | 2 |
| Acute Disease | 1 |
Trials
Showing 51 to 64 of 64. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.